Skip to main content
. 2022 Mar 12;22:131. doi: 10.1186/s12887-022-03192-7

Table 2.

Lipid apheresis: Lipid levels at baseline and after 3 years of lipid apheresis

Patient LDL-C [mg/dL] on max. Oral medication Steady state Pre-LA
LDL-C [mg/dL]		 Steady state Post-LA
LDL-C [mg/dL]
1 688.8a 411.2 (288.8-564.6) 153.5 (113.8-227.8)
2 535.4 (534.8-536.0) 337.2 (265.0-443.0) 104.7 (84.8-151.6)
3 597.1 (521.2-732.0) 244.2b (223.0-287.4) 81.0b (67.4-99.0)
4 742.0a 251.7 (205.0-297.4) 76.4 (57.2-94.8)

Values at baseline are on maximum oral medication with statins and ezetimibe in all patients and colesevelam in Patient 2. Lipid values were measured before and after weekly/biweekly LA. Values are displayed as means, minimum and maximum over a period of 3 months. aonly one measurement available. bbiweekly